squaric acid dibutyl ester has been researched along with diphenylcyclopropenone in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (27.27) | 18.7374 |
| 1990's | 8 (36.36) | 18.2507 |
| 2000's | 4 (18.18) | 29.6817 |
| 2010's | 3 (13.64) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Boezeman, JB; Happle, R; van der Steen, PH | 1 |
| Bröcker, EB; Hamm, H; John, SM; Steinhausen, D | 1 |
| Happle, R; Perret, CM; Steijlen, PM; Zaun, H | 1 |
| Cainelli, T; Naldi, L; Parazzini, F | 1 |
| Happle, R; Perret, CM; Steijlen, PM | 1 |
| Bardazzi, F; Guerra, L; Tosti, A | 1 |
| Gasponi, A; Manuzzi, P; Tosti, A | 1 |
| Brasile, GP; Capobianco, C; Guerra, L; Tosti, A | 1 |
| Orecchia, G; Rabbiosi, G | 1 |
| De Padova, MP; Minghetti, G; Tosti, A; Veronesi, S | 1 |
| Shapiro, J | 2 |
| Happle, R; van der Steen, PH | 1 |
| Rokhsar, CK; Shupack, JL; Vafai, JJ; Washenik, K | 1 |
| Buckley, DA; du Vivier, AW | 1 |
| Henderson, RL; McMichael, AJ | 1 |
| Inui, S; Itami, S; Nakajima, T; Toda, N | 1 |
| Burkhart, CN; Dasher, DA; Morrell, DS | 1 |
| Burkhart, CN; Morrell, DS; Mukherjee, N | 1 |
| Aiba, S; Fujimura, T; Furudate, S; Haga, T; Hashimoto, A; Kakizaki, A; Kambayashi, Y | 1 |
| Kim, BJ; Lee, S; Lee, WS; Lee, YB | 1 |
| Gómez-Flores, M; Herz-Ruelas, ME; Lozano-Peña, AK; Ocampo-Candiani, J; Vázquez-Martínez, O; Welsh-Lozano, O | 1 |
10 review(s) available for squaric acid dibutyl ester and diphenylcyclopropenone
| Article | Year |
|---|---|
Role of topical immunotherapy in the treatment of alopecia areata. Quality analysis of articles published between January 1977 and January 1988 about three treatments. Reading Group.
Topics: Administration, Cutaneous; Alopecia Areata; Cyclobutanes; Cyclopropanes; Dinitrochlorobenzene; Humans; Immunotherapy; Meta-Analysis as Topic | 1990 |
[Alopecia areata; pathogenesis and topical immunotherapy].
Topics: Allergens; Alopecia Areata; Cyclobutanes; Cyclopropanes; Female; Humans; Male | 1989 |
Topical immunotherapy in the treatment of chronic severe alopecia areata.
Topics: Administration, Topical; Allergens; Alopecia Areata; Chronic Disease; Cyclobutanes; Cyclopropanes; Dinitrochlorobenzene; Hair; Humans; Immunotherapy | 1993 |
Efficacy of topical sensitizers in the treatment of alopecia areata.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Alopecia Areata; Cyclobutanes; Cyclopropanes; Hair; Humans; Prognosis; Safety | 1998 |
Topical immunotherapy in dermatology.
Topics: Administration, Topical; Allergens; Alopecia Areata; Cyclobutanes; Cyclopropanes; Decision Making; Dinitrochlorobenzene; Humans; Immunotherapy; Warts | 1999 |
Topical sensitizers in alopecia areata.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Alopecia Areata; Cyclobutanes; Cyclopropanes; Dinitrochlorobenzene; Humans; Inflammation; Irritants; Patient Selection; Prognosis; Severity of Illness Index; Treatment Outcome | 2004 |
Immunotherapy for childhood warts.
Topics: Adjuvants, Immunologic; Aminoquinolines; Antigens; Child; Child, Preschool; Cimetidine; Cyclobutanes; Cyclopropanes; Dinitrochlorobenzene; Histamine H2 Antagonists; Humans; Imiquimod; Immunotherapy; Injections, Intralesional; Irritants; Treatment Outcome; Warts | 2009 |
Treatment of alopecia areata in children.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Alopecia Areata; Anthralin; Child; Child, Preschool; Cyclobutanes; Cyclopropanes; Dermatologic Agents; Dinitrochlorobenzene; Glucocorticoids; Humans; Immunosuppressive Agents; Immunotherapy; Minoxidil; Phototherapy; Practice Guidelines as Topic; Treatment Outcome; Vasodilator Agents | 2009 |
Current treatment of alopecia areata.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Alopecia Areata; Anthralin; Cyclobutanes; Cyclopropanes; Cyclosporine; Dermatologic Agents; Humans; Immunosuppressive Agents; Injections, Intralesional; Methotrexate; Minoxidil; PUVA Therapy; Self-Help Groups | 2013 |
Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.
Topics: Adjuvants, Immunologic; Alopecia; Alopecia Areata; Cyclobutanes; Cyclopropanes; Hair; Humans; Immunotherapy; Recurrence | 2018 |
1 trial(s) available for squaric acid dibutyl ester and diphenylcyclopropenone
| Article | Year |
|---|---|
Therapies versus placebo in the treatment of patchy alopecia areata.
Topics: Adolescent; Adult; Age Factors; Aged; Alopecia Areata; Child; Child, Preschool; Clinical Trials as Topic; Cyclobutanes; Cyclopropanes; Female; Humans; Male; Middle Aged; Minoxidil; Placebos | 1986 |
11 other study(ies) available for squaric acid dibutyl ester and diphenylcyclopropenone
| Article | Year |
|---|---|
Topical immunotherapy for alopecia areata: re-evaluation of 139 cases after an additional follow-up period of 19 months.
Topics: Administration, Topical; Alopecia Areata; Cyclobutanes; Cyclopropanes; Follow-Up Studies; Humans; Immunotherapy; Male; Prognosis | 1992 |
Topical immunotherapy with contact allergens in alopecia areata: evidence for non-specific systemic suppression of cellular immune reactions.
Topics: Administration, Cutaneous; Adolescent; Adult; Allergens; Alopecia Areata; Cyclobutanes; Cyclopropanes; Female; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Immunotherapy; Male; Middle Aged | 1991 |
Erythema multiforme-like eruptions: a rare side effect of topical immunotherapy with diphenylcyclopropenone.
Topics: Administration, Topical; Adult; Alopecia Areata; Cyclobutanes; Cyclopropanes; Drug Eruptions; Erythema Multiforme; Female; Humans; Middle Aged | 1990 |
Contact urticaria during topical immunotherapy.
Topics: Administration, Topical; Adult; Alopecia Areata; Cyclobutanes; Cyclopropanes; Dermatitis, Contact; Dinitrochlorobenzene; Female; Humans; Immunotherapy; Male; Urticaria | 1989 |
Thymopentin in the treatment of severe alopecia areata.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Alopecia Areata; Cyclobutanes; Cyclopropanes; Female; Humans; Male; Middle Aged; Peptide Fragments; Thymopentin; Thymopoietins; Thymus Hormones | 1988 |
[Sensitization therapy in severe alopecia areata].
Topics: Adolescent; Adult; Aged; Allergens; Alopecia Areata; Child; Child, Preschool; Cyclobutanes; Cyclopropanes; Female; Humans; Immunization; Male; Middle Aged | 1988 |
Patterns of hair regrowth in alopecia areata.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Alopecia Areata; Child; Cyclobutanes; Cyclopropanes; Female; Hair; Humans; Male; Minoxidil | 1988 |
Topical immunotherapy of alopecia areata.
Topics: Administration, Topical; Allergens; Alopecia Areata; Cyclobutanes; Cyclopropanes; Hair; Humans; Immunotherapy | 1993 |
Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Alopecia Areata; Child; Child, Preschool; Cyclobutanes; Cyclopropanes; Dermatologic Agents; Female; Humans; Hypersensitivity; Immunotherapy; Male; Middle Aged; Retrospective Studies; Terfenadine; Young Adult | 2009 |
Contact immunotherapy enhances the therapeutic effects of nivolumab in treating in-transit melanoma: Two cases reports.
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Cyclobutanes; Cyclopropanes; Female; Humans; Immunotherapy; Male; Melanoma; Nivolumab; Skin Neoplasms | 2016 |
Immunotherapy for resistant and/or severe alopecia areata in a university hospital setting in Northern Mexico.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Alopecia Areata; Child; Child, Preschool; Cyclobutanes; Cyclopropanes; Female; Hospitals, University; Humans; Immunotherapy; Male; Mexico; Middle Aged; Retrospective Studies; Young Adult | 2020 |